Merck KGaA Company Profile (FRA:MRK)

About Merck KGaA

Merck KGaA logo.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: FRA
  • Symbol: MRK
  • CUSIP:
Key Metrics:
  • Previous Close: $96.10
  • 50 Day Moving Average: $96.424
  • 200 Day Moving Average: $91.322
  • Trailing P/E Ratio: 30.068
  • P/E Growth: 1.300
  • Market Cap: $41.78B
Additional Links:
Companies Related to Merck KGaA:

Analyst Ratings

Consensus Ratings for Merck KGaA (FRA:MRK) (?)
Ratings Breakdown: 1 Sell Rating, 12 Hold Ratings, 10 Buy Ratings
Consensus Rating:Hold (Score: 2.39)
Consensus Price Target: €101.19

Analysts' Ratings History for Merck KGaA (FRA:MRK)
DateFirmActionRatingPrice TargetDetails
10/24/2016DZ Bank AGReiterated RatingBuyView Rating Details
10/17/2016Societe GeneraleSet Price TargetNeutral€97.00View Rating Details
10/17/2016Goldman Sachs Group Inc.Set Price TargetNeutral€99.00View Rating Details
10/14/2016JPMorgan Chase & Co.Reiterated RatingNeutralView Rating Details
10/14/2016Bankhaus LampeSet Price TargetBuy€112.00View Rating Details
10/14/2016Morgan StanleySet Price TargetNeutral€103.00View Rating Details
10/14/2016S&P Global Inc.Set Price TargetNeutral€103.00View Rating Details
10/14/2016Berenberg BankSet Price TargetNeutral€101.00View Rating Details
10/14/2016Commerzbank AGSet Price TargetBuy€101.00View Rating Details
10/14/2016equinet AGSet Price TargetNeutral€91.00View Rating Details
9/30/2016BNP ParibasSet Price TargetBuy€114.00View Rating Details
9/29/2016Citigroup Inc.Set Price TargetBuy€115.00View Rating Details
9/8/2016Bank of America Corp.Set Price TargetBuy€115.00View Rating Details
8/5/2016Nord/LBSet Price TargetBuy€112.00View Rating Details
8/5/2016Credit Suisse Group AGSet Price TargetBuy€108.00View Rating Details
8/5/2016Baader BankSet Price TargetNeutral€97.00View Rating Details
8/4/2016Independent Research GmbHSet Price TargetNeutral€102.00View Rating Details
8/4/2016Warburg ResearchSet Price TargetBuy€103.10View Rating Details
7/28/2016Deutsche Bank AGSet Price TargetBuy€110.00View Rating Details
5/10/2016Barclays PLCSet Price TargetNeutral€87.00View Rating Details
3/9/2016HSBCSet Price TargetNeutral€88.00View Rating Details
12/11/2015S&P Equity ResearchSet Price TargetNeutral€104.00View Rating Details
12/7/2015Kepler Capital MarketsSet Price TargetSell€75.00View Rating Details
(Data available from 10/26/2014 forward)


Earnings History for Merck KGaA (FRA:MRK)
No earnings announcements for this company have been tracked by


Earnings Estimates for Merck KGaA (FRA:MRK)
No earnings estimates for this company have been tracked by


Dividend History for Merck KGaA (FRA:MRK)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Merck KGaA (FRA:MRK)
No insider trades for this company have been tracked by


Latest Headlines for Merck KGaA (FRA:MRK)
News Icon(NYSE:MRK) Reported 0.93 EPS in the last quarter (FRA:MRK) - October 23 at 10:32 AM
News IconMerck KGaA expands biologics site that produces hot-selling Gonal-f (FRA:MRK) - October 18 at 11:33 AM logoPeregrine Pharmaceuticals - A Misunderstood And Undervalued Biotech With Significant Upside Potential (FRA:MRK) - October 17 at 6:09 PM logoPharma Stock Roundup: Mylan in EpiPen Medicaid Settlement, ESMO Data in Focus (FRA:MRK) - October 14 at 9:32 AM logoMerck KGaA (MRK) - Medical Equipment - Deals and Alliances Profile - New Market Report (FRA:MRK) - October 13 at 6:19 PM
News IconGerman Merck, Vaccinex ink lung cancer anti-PD-L1 combo trial deal (FRA:MRK) - October 8 at 5:50 PM logoGermany stocks mixed at close of trade; DAX up 0.19% (FRA:MRK) - September 22 at 11:02 AM logoEU court says Lundbeck pay-for-delay deals anti-competitive (FRA:MRK) - September 9 at 10:55 AM logoSyndax Pharmaceuticals: A Potential Bio Run-Up Play For 2017 (FRA:MRK) - September 1 at 9:23 AM logoHow Much Medivation Can Really Fetch in a Buyout (FRA:MRK) - August 30 at 9:36 AM logoTraders Likely to Wait and Watch Amid Strong Data (FRA:MRK) - August 27 at 10:37 AM logoMylan offers discounts on EpiPen amid wave of criticism (FRA:MRK) - August 25 at 6:13 PM
News IconUPDATED: Pfizer buys Medivation for $81.50 a share (FRA:MRK) - August 22 at 10:51 AM logoShares fall after trial fail for Juniper Pharmaceuticals (FRA:MRK) - August 19 at 6:12 PM logoEuropean stocks mostly lower with eyes on Fed minutes; DAX down 0.27% (FRA:MRK) - August 17 at 9:22 AM logoRemicade Is Driving Down Merck’s Immunology Franchise (FRA:MRK) - August 16 at 6:24 PM logoGermany stocks mixed at close of trade; DAX down 0.07% (FRA:MRK) - August 1 at 6:03 PM
News IconAfter PhIII disaster, NewLink Genetics plots reorganization (FRA:MRK) - July 29 at 6:25 PM logoMerck’s 2Q16 Estimates: Expect Operational Growth in Revenues (FRA:MRK) - July 27 at 9:12 AM logoWhat to Expect from Merck’s 2Q16 Earnings (FRA:MRK) - July 27 at 6:47 AM logoGermany stocks higher at close of trade; DAX up 0.50% (FRA:MRK) - July 26 at 9:31 AM logoMerck (MRK) Stock Down, Ebola Vaccine Under 'Accelerated' FDA Review (FRA:MRK) - July 25 at 10:47 AM logoA report released earlier today by Independent Research GmbH about (ETR:MRK) Merck ups the target price to 99EUR (FRA:MRK) - July 24 at 5:50 PM logoBig Pharma eyes Bay Area, Boston expansions as it cuts R&D elsewhere (FRA:MRK) - July 12 at 5:30 PM logoMerck (MRK) Stock Gaining, Cutting Research Jobs (FRA:MRK) - July 12 at 2:59 PM logo[$$] Merck to Cut Research Jobs at Three East-Coast Sites (FRA:MRK) - July 12 at 2:52 PM logoMerck And Premier Join Hands To Prevent Fractures For Osteoporosis Patients (FRA:MRK) - June 30 at 10:32 AM logoGilead Sciences: Dominating (FRA:MRK) - June 28 at 2:28 PM logoGermany stocks higher at close of trade; DAX up 1.85% (FRA:MRK) - June 23 at 6:43 PM logoGermany stocks higher at close of trade; DAX up 0.92% (FRA:MRK) - June 15 at 6:15 PM
News IconFDA’s Pazdur chides biopharma for falling into an I/O rut (FRA:MRK) - June 14 at 6:01 PM
News IconRegulator says too many drugmakers chasing same cancer strategy (FRA:MRK) - June 10 at 6:30 PM
News IconToo Many Drug Companies Chasing Same Cancer Strategy: FDA (FRA:MRK) - June 10 at 6:30 PM logoGermany stocks lower at close of trade; DAX down 2.52% (FRA:MRK) - June 10 at 6:30 PM
News IconMerck KGaA (MRK) Given a €99.00 Price Target at Berenberg Bank (FRA:MRK) - June 1 at 6:43 PM
News IconMerck KGaA (MRK) Given a €99.00 Price Target by Berenberg Bank Analysts (FRA:MRK) - June 1 at 6:43 PM logoCancer Immunotherapies Take Center Stage in Pre-ASCO Abstract Releases - Motley Fool (FRA:MRK) - May 27 at 2:44 PM logoMerck Expands Production Know-how to Deliver Full End-To-End Solution for Biopharma Industry (FRA:MRK) - May 2 at 8:10 AM logoMerck Accelerator goes global with launch in Africa (FRA:MRK) - January 28 at 6:11 AM logoMerck Announces New Biopharma Heads for North America and China (FRA:MRK) - January 27 at 7:34 AM logoMerck CEO rules out major acquisitions in 2016 (FRA:MRK) - January 21 at 12:06 PM logoMerck and BrandWatch Technologies Form Long-Term Partnership (FRA:MRK) - January 21 at 4:05 AM logoMerck launches Vivera in Latin America (FRA:MRK) - January 20 at 4:05 AM logoMerck Appoints New Executive Board Members (FRA:MRK) - January 19 at 2:05 AM
News IconIt's Merck vs. Merck as name confusion, complicated by social media, leads to legal showdown (FRA:MRK) - January 17 at 6:45 PM logoMiraval® Cosmic Bronze – The Second Effect Pigment in the New Product Series from Merck (FRA:MRK) - November 30 at 4:06 AM logoGray Modules: New Dimension in Organic Photovoltaics for Buildings (FRA:MRK) - November 26 at 1:06 AM logoMerck and Pfizer Receive Positive Opinion for Orphan Drug Designation for Avelumab in Merkel Cell Carcinoma from EMA Committee for Orphan Medicinal Products (FRA:MRK) - November 25 at 4:15 AM logoMerck Counts on Africa for Growth (FRA:MRK) - November 20 at 2:08 AM logoMerck and the University of Cape Town to Develop a Drug Discovery Platform for Malaria (FRA:MRK) - November 19 at 8:08 AM


Last Updated on 10/26/2016 by Staff